Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.65 |
| ▸ | TUBB1 | Q9H4B7 | 6/20 | 0.56 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.51 |
| ▸ | TUBB | P07437 | 2/20 | 0.51 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.51 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.51 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.51 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.51 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.51 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.51 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.51 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.51 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.51 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.51 |
| ▸ | TUBB6 | Q9BUF5 | 2/20 | 0.51 |
| ▸ | TUBB2B | Q9BVA1 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12903076 | 1.00 | TYR (0.65) | TYRTUBB1TUBB4ATUBBTUBA3C | |
| Methylisoeugenol SCHEMBL29518298 | 0.83 | TYR (0.69) | TYRTUBB1TUBB4ATUBBTUBA3C | |
| Methylisoeugenol SCHEMBL29364555 | 0.83 | TYR (0.69) | TYRTUBB1TUBB4ATUBBTUBA3C | |
| Methylisoeugenol SCHEMBL112937 | 0.83 | TYR (0.69) | TYRTUBB1TUBB4ATUBBTUBA3C | |
| Methylisoeugenol SCHEMBL1760676 | 0.83 | TYR (0.69) | TYRTUBB1TUBB4ATUBBTUBA3C | |
| Methylisoeugenol SCHEMBL30203196 | 0.83 | TYR (0.69) | TYRTUBB1TUBB4ATUBBTUBA3C | |
| Methylisoeugenol SCHEMBL1532669 | 0.83 | TYR (0.69) | TYRTUBB1TUBB4ATUBBTUBA3C | |
| Methylisoeugenol SCHEMBL28544349 | 0.82 | TYR (0.67) | TYRTUBB1TUBB4ATUBBTUBA3C | |
| Methylisoeugenol SCHEMBL28577260 | 0.82 | TYR (0.67) | TYRTUBB1TUBB4ATUBBTUBA3C | |
| SCHEMBL27943686 | 0.80 | TYR (0.65) | TYRTUBB1TUBB4ATUBBTUBA3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230232831-A1 | MONOTERPENOID AND PHENYLPROPANOID CARBONATE ESTERS AND METHODS OF THEIR MAKING AND USE AS REPELLENTS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2023-07-27 | — | — | US | disclosed |
| US-20230232831-A1 | MONOTERPENOID AND PHENYLPROPANOID CARBONATE ESTERS AND METHODS OF THEIR MAKING AND USE AS REPELLENTS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2023-07-27 | — | — | US | disclosed |
| US-20170360665-A1 | NOVEL 1-PHENYLMONO- OR -POLYHYDROXYPROPANE COMPOUNDS, COMPOSITIONS AND COSMETIC USES THEREOF | L'OREAL (FR) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230232831-A1 | MONOTERPENOID AND PHENYLPROPANOID CARBONATE ESTERS AND METHODS OF THEIR MAKING AND USE AS REPELLENTS | CYP51A1, CYP17A1, CYP4A11 | TYR 684/4885TUBB1 3068/4885TUBB4A 2087/4885 |
| US-20170360665-A1 | NOVEL 1-PHENYLMONO- OR -POLYHYDROXYPROPANE COMPOUNDS, COMPOSITIONS AND COSMETIC USES THEREOF | GLA, PAH, P4HA1 | TYR 4/4885TUBB1 2449/4885TUBB4A 2709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.